Dexcom President and CEO Kevin Sayer is “incredibly proud” of what the company is calling “resilient growth” in the second quarter of 2020, according to an earnings call on Tuesday.
Despite having some uncertainty in the impacts of the COVID-19 pandemic, Dexcom was able to produce significant year-over-year growth in Q2 2020.
Sayer attributes much of the growth to a steady increase in knowledge...
Teladoc Health continues its strong upward trend during its second fiscal quarter, with CEO Jason Gorevic informing investors yesterday that the company had outperformed "all key financial and operation metrics."
Similar to the first quarter, the telehealth company is touting massive year-over-year (YoY) growth in revenue, visit volume and new registrations, as well as the acquisition of several...
Following another rough quarter, NeuroMetrix has sought outside help in an effort to restructure its business and is pivoting away from a direct-to-consumer business model for its wearable pain relief platform, Quell.
“NeuroMetrix has good product lines and technology, and more broadly, the company has real value,” Dr. Shai Gozani, CEO and president of NeuroMetrix, told investors in a recent...
Wearables, services perform well for Apple. While iPhone sales and overall Q2 revenue were down in 2019, the company was fairly optimistic on its most recent earnings report due to substantial growth among its wearables, iPads and services businesses.
In terms of healthcare, CEO Tim Cook noted during the investors’ call that the past quarter included the rollout of the Apple Watch Series 4’s ECG...
